$EKSO
EKSO BIONICS HOLDINGS, INC.

2024 Q3 Form 10-Q Financial Statement

#000143774924023765 Filed on July 29, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2
Revenue $4.129M $4.950M
YoY Change -10.38% 5.25%
Cost Of Revenue $1.920M $2.313M
YoY Change -10.74% -5.55%
Gross Profit $2.209M $2.637M
YoY Change -10.06% 16.99%
Gross Profit Margin 53.5% 53.27%
Selling, General & Admin $4.071M $3.856M
YoY Change -3.71% -24.98%
% of Gross Profit 184.29% 146.23%
Research & Development $777.0K $1.116M
YoY Change -32.96% -20.17%
% of Gross Profit 35.17% 42.32%
Depreciation & Amortization $407.0K $397.0K
YoY Change 19.71% 48.69%
% of Gross Profit 18.42% 15.05%
Operating Expenses $4.848M $4.972M
YoY Change -10.01% -23.95%
Operating Profit -$2.639M -$2.335M
YoY Change -9.96% -45.49%
Interest Expense $555.0K -$165.0K
YoY Change 767.19% 142.65%
% of Operating Profit
Other Income/Expense, Net $567.0K -$81.00K
YoY Change -230.65% -166.39%
Pretax Income -$2.072M -$2.416M
YoY Change -38.52% -42.88%
Income Tax
% Of Pretax Income
Net Earnings -$2.072M -$2.416M
YoY Change -38.42% -42.88%
Net Earnings / Revenue -50.18% -48.81%
Basic Earnings Per Share -$0.10 -$0.13
Diluted Earnings Per Share -$0.10 -$0.13
COMMON SHARES
Basic Shares Outstanding 18.44M 18.17M
Diluted Shares Outstanding 20.31M 18.22M

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $8.292M $5.885M
YoY Change -16.58% -55.78%
Cash & Equivalents $8.292M $5.885M
Short-Term Investments
Other Short-Term Assets $779.0K $1.263M
YoY Change -27.2% 66.4%
Inventory $5.031M $4.974M
Prepaid Expenses
Receivables $6.964M $6.520M
Other Receivables $0.00 $0.00
Total Short-Term Assets $21.07M $18.64M
YoY Change -5.8% -24.59%
LONG-TERM ASSETS
Property, Plant & Equipment $1.628M $1.748M
YoY Change -21.96% -49.33%
Goodwill $431.0K $431.0K
YoY Change 0.0% 0.0%
Intangibles $4.662M $4.739M
YoY Change -6.23% -6.21%
Long-Term Investments
YoY Change
Other Assets $531.0K $435.0K
YoY Change 90.32% 31.02%
Total Long-Term Assets $8.143M $8.342M
YoY Change -7.69% -9.97%
TOTAL ASSETS
Total Short-Term Assets $21.07M $18.64M
Total Long-Term Assets $8.143M $8.342M
Total Assets $29.21M $26.98M
YoY Change -6.33% -20.6%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.808M $2.125M
YoY Change -27.74% -32.65%
Accrued Expenses $1.975M $1.973M
YoY Change -5.77% -28.28%
Deferred Revenue $2.039M $1.926M
YoY Change 24.71% 49.77%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $1.250M $1.250M
YoY Change 0.0% -57.44%
Total Short-Term Liabilities $7.506M $7.704M
YoY Change -4.19% -23.94%
LONG-TERM LIABILITIES
Long-Term Debt $4.106M $4.352M
YoY Change -19.01% 31.84%
Other Long-Term Liabilities $165.0K $145.0K
YoY Change 68.37% -94.73%
Total Long-Term Liabilities $165.0K $145.0K
YoY Change 68.37% -97.6%
TOTAL LIABILITIES
Total Short-Term Liabilities $7.506M $7.704M
Total Long-Term Liabilities $165.0K $145.0K
Total Liabilities $14.34M $14.93M
YoY Change -9.96% -7.75%
SHAREHOLDERS EQUITY
Retained Earnings -$247.1M -$245.0M
YoY Change 4.72% 5.34%
Common Stock $22.00K $19.00K
YoY Change 57.14% 35.71%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $14.87M $12.06M
YoY Change
Total Liabilities & Shareholders Equity $29.21M $26.98M
YoY Change -6.33% -20.6%

Cashflow Statement

Concept 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income -$2.072M -$2.416M
YoY Change -38.42% -42.88%
Depreciation, Depletion And Amortization $407.0K $397.0K
YoY Change 19.71% 48.69%
Cash From Operating Activities -$2.277M -$2.670M
YoY Change -32.03% -8.03%
INVESTING ACTIVITIES
Capital Expenditures $8.000K $0.00
YoY Change -20.0% -100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$8.000K $0.00
YoY Change -20.0% -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 4.691M -265.0K
YoY Change
NET CHANGE
Cash From Operating Activities -2.277M -2.670M
Cash From Investing Activities -8.000K 0.000
Cash From Financing Activities 4.691M -265.0K
Net Change In Cash 2.406M -2.935M
YoY Change -171.61% -0.78%
FREE CASH FLOW
Cash From Operating Activities -$2.277M -$2.670M
Capital Expenditures $8.000K $0.00
Free Cash Flow -$2.285M -$2.670M
YoY Change -31.99% -9.74%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
28000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
79000 usd
CY2024Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2024Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2024Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
141429000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
141429000
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
18444000
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
18444000
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14848000
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14848000
CY2024Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2024Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2024Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
ekso Below Market Lease Amortization Period
BelowMarketLeaseAmortizationPeriod
P1Y
CY2023Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
138000 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
271000 usd
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
141429000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
18444000
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14848000
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14848000
CY2024Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
ekso Class Of Warrant Or Warrants Exercised
ClassOfWarrantOrWarrantsExercised
0
CY2023Q2 ekso Class Of Warrant Or Warrants Exercised
ClassOfWarrantOrWarrantsExercised
0
ekso Class Of Warrant Or Warrants Exercised
ClassOfWarrantOrWarrantsExercised
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2024Q2 ekso Number Of License Agreements
NumberOfLicenseAgreements
2 pure
CY2024Q2 ekso Number Of License Agreements
NumberOfLicenseAgreements
2 pure
us-gaap Longterm Purchase Commitment Period
LongtermPurchaseCommitmentPeriod
P1Y
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 pure
CY2024Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-37854
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
99-0367049
dei Entity Address Address Line1
EntityAddressAddressLine1
101 Glacier Point, Suite A
dei Entity Address City Or Town
EntityAddressCityOrTown
San Rafael
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94901
dei City Area Code
CityAreaCode
510
dei Local Phone Number
LocalPhoneNumber
984-1761
dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value per share
dei Trading Symbol
TradingSymbol
EKSO
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
18444181
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5885000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8638000 usd
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
6520000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5645000 usd
CY2024Q2 us-gaap Inventory Net
InventoryNet
4974000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
5050000 usd
CY2024Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1263000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
875000 usd
CY2024Q2 us-gaap Assets Current
AssetsCurrent
18642000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
20208000 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1748000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2018000 usd
CY2024Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
989000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
977000 usd
CY2024Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
4739000 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
4892000 usd
CY2024Q2 us-gaap Goodwill
Goodwill
431000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
431000 usd
CY2024Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
435000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
392000 usd
CY2024Q2 us-gaap Assets
Assets
26984000 usd
CY2023Q4 us-gaap Assets
Assets
28918000 usd
CY2024Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
2125000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1847000 usd
CY2024Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1973000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2664000 usd
CY2024Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1926000 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1993000 usd
CY2024Q2 us-gaap Notes Payable Current
NotesPayableCurrent
1250000 usd
CY2023Q4 us-gaap Notes Payable Current
NotesPayableCurrent
1250000 usd
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
430000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
363000 usd
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
7704000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
8117000 usd
CY2024Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
2016000 usd
CY2023Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
2169000 usd
CY2024Q2 us-gaap Long Term Notes Payable
LongTermNotesPayable
4352000 usd
CY2023Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
4832000 usd
CY2024Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
659000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
723000 usd
CY2024Q2 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
49000 usd
CY2023Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
366000 usd
CY2024Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
145000 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
105000 usd
CY2024Q2 us-gaap Liabilities
Liabilities
14925000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
16312000 usd
CY2024Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
19000 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
15000 usd
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
256491000 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
251580000 usd
CY2024Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
539000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
156000 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-244990000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-239145000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
12059000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
12606000 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
26984000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
28918000 usd
CY2024Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
4950000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
4703000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
8706000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
8825000 usd
CY2024Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2313000 usd
CY2023Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2449000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
4118000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
4571000 usd
CY2024Q2 us-gaap Gross Profit
GrossProfit
2637000 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
2254000 usd
us-gaap Gross Profit
GrossProfit
4588000 usd
us-gaap Gross Profit
GrossProfit
4254000 usd
CY2024Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1846000 usd
CY2023Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2349000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3664000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
4437000 usd
CY2024Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1116000 usd
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1398000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2252000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2552000 usd
CY2024Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2010000 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2791000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4263000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5997000 usd
CY2024Q2 us-gaap Operating Expenses
OperatingExpenses
4972000 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
6538000 usd
us-gaap Operating Expenses
OperatingExpenses
10179000 usd
us-gaap Operating Expenses
OperatingExpenses
12986000 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-2335000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-4284000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-5591000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-8732000 usd
CY2024Q2 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
74000 usd
CY2023Q2 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
61000 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
131000 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
172000 usd
CY2024Q2 ekso Gain Loss On Warrant Modification
GainLossOnWarrantModification
0 usd
CY2023Q2 ekso Gain Loss On Warrant Modification
GainLossOnWarrantModification
0 usd
ekso Gain Loss On Warrant Modification
GainLossOnWarrantModification
-109000 usd
ekso Gain Loss On Warrant Modification
GainLossOnWarrantModification
0 usd
CY2024Q2 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
84000 usd
CY2023Q2 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
152000 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
426000 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
126000 usd
CY2024Q2 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-91000 usd
CY2023Q2 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-7000 usd
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-440000 usd
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
210000 usd
CY2024Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-30000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-51000 usd
CY2024Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-81000 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
54000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-254000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
113000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-2416000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-4230000 usd
us-gaap Net Income Loss
NetIncomeLoss
-5845000 usd
us-gaap Net Income Loss
NetIncomeLoss
-8619000 usd
CY2024Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
92000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-10000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
383000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-204000 usd
CY2024Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2324000 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4240000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-5462000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-8823000 usd
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.13
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.31
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.33
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.64
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18224000
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13637000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17822000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13467000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
12606000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-3429000 usd
CY2024Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
3970000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
237000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
376000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
291000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
14051000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-2416000 usd
CY2024Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
47000 usd
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
284000 usd
CY2024Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
92000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
12059000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
25442000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-4389000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
424000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-194000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
21283000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-4230000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
249000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
514000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-10000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
17807000 usd
us-gaap Net Income Loss
NetIncomeLoss
-5845000 usd
us-gaap Net Income Loss
NetIncomeLoss
-8619000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
803000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
842000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
39000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
16000 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
426000 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
126000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
660000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
938000 usd
ekso Gain Loss On Warrant Modification
GainLossOnWarrantModification
-109000 usd
ekso Gain Loss On Warrant Modification
GainLossOnWarrantModification
-0 usd
ekso Common Stock Contribution
CommonStockContribution
113000 usd
ekso Common Stock Contribution
CommonStockContribution
219000 usd
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-440000 usd
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
210000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1029000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
518000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
9000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
283000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
387000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
62000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
281000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-13000 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-681000 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-61000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-204000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
760000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6136000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7117000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
8000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
97000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-8000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-97000 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
625000 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
-0 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
4017000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3392000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-1000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-4000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2753000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-7218000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
8638000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
20525000 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
5885000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
13307000 usd
us-gaap Interest Paid Net
InterestPaidNet
96000 usd
us-gaap Interest Paid Net
InterestPaidNet
98000 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
8000 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
32000 usd
ekso Transfer Of Property And Equipment From Inventory
TransferOfPropertyAndEquipmentFromInventory
72000 usd
ekso Transfer Of Property And Equipment From Inventory
TransferOfPropertyAndEquipmentFromInventory
-131000 usd
ekso Operating Leases Liability Right Of Use Asset Initial Recognition
OperatingLeasesLiabilityRightOfUseAssetInitialRecognition
180000 usd
ekso Operating Leases Liability Right Of Use Asset Initial Recognition
OperatingLeasesLiabilityRightOfUseAssetInitialRecognition
0 usd
us-gaap Stock Issued1
StockIssued1
1000 usd
us-gaap Stock Issued1
StockIssued1
0 usd
ekso Shares Issued Capital Contribution
SharesIssuedCapitalContribution
238000 usd
ekso Shares Issued Capital Contribution
SharesIssuedCapitalContribution
249000 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-244990000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6136000 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5885000 usd
CY2024Q2 ekso Debt Covenant Covenant Compliance Unrestricted Cash
DebtCovenantCovenantComplianceUnrestrictedCash
2000000 usd
ekso Unrestricted Cash
UnrestrictedCash
3885000 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>Use of Estimates</i></b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The preparation of the condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the balance sheet, and the reported amounts of revenues and expenses during the reporting period. For the Company, these estimates include, but are <em style="font: inherit;">not</em> limited to, assets acquired and liabilities assumed in business combinations, revenue recognition, deferred revenue, the valuation of warrants and employee equity awards, future warranty costs, accounting for leases, useful lives assigned to long-lived assets, valuation of inventory, realizability of deferred tax assets, and contingencies. Actual results could differ from those estimates.</p> <p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"></p>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>Concentration of Credit Risk and Other Risks and Uncertainties</i></b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and accounts receivable. The Company has significant cash balances at foreign financial institutions which throughout the year regularly exceed the applicable country cash deposit insurance limits of approximately <em style="font: inherit;">$100</em> at each of the Company's <em style="font: inherit;">two</em> foreign banks. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company's financial condition, results of operations, and cash flows. The Company's cash balances held in domestic banks are deposited into accounts at various institutions with each balance under the <em style="font: inherit;">$250</em> Federal Deposit Insurance Corporation ("FDIC") insurance limit. The Company extends credit to customers in the normal course of business. Concentrations of credit risk with respect to accounts receivable exist to the full extent of amounts presented in the condensed consolidated financial statements. The Company does <em style="font: inherit;">not</em> require collateral from its customers to secure accounts receivable.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Accounts receivable are derived from the sale of products shipped and services performed for customers primarily located in the U.S., Europe, Asia, and Australia. Invoices are aged based on contractual terms with the customer. The Company reviews accounts receivable for collectability and provides an allowance for potential credit losses. The allowance for potential credit losses on trade receivables reflects the Company’s best estimate of probable losses inherent in the accounts receivable balance based on known troubled accounts, historical experience, and other currently available evidence. Payment terms and conditions vary by contract type, although terms generally include a requirement of payment within <em style="font: inherit;">30</em> to <em style="font: inherit;">90</em> days. The Company has <em style="font: inherit;">not</em> experienced material losses related to accounts receivable as of <em style="font: inherit;"> June 30, 2024</em> and <em style="font: inherit;"> December 31, 2023</em>.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Many of the sales contracts with customers outside of the U.S. are settled in a foreign currency other than the U.S. dollar. The Company does <em style="font: inherit;">not</em> enter into any foreign currency hedging agreements and is susceptible to gains and losses from foreign currency fluctuations. To date, the Company has <em style="font: inherit;">not</em> experienced significant gains or losses upon collecting receivables denominated in a foreign currency.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company had<span style="background-color:#ffffff;"> <span style="-sec-ix-hidden:c114144067">two</span></span> customers with an accounts receivable balance totaling <em style="font: inherit;">10%</em> or more of the Company’s total accounts receivable as of <em style="font: inherit;"> June 30, 2024</em><span style="background-color:#ffffff;"> (15% and 10%), as</span> compared with <em style="font: inherit;">no</em> customers as of <em style="font: inherit;"> December 31, 2023</em>.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">During the <em style="font: inherit;">three</em> months ended <em style="font: inherit;"> June 30, 2024</em>, the Company had <span style="-sec-ix-hidden:c114144073">two</span> customers with sales of <em style="font: inherit;">10%</em> or more of the Company’s total reven<span style="background-color:#ffffff;">ue (11% and 10%), as</span> compared with <span style="-sec-ix-hidden:c114144077">three</span> customers in the <em style="font: inherit;">three</em> months ended <em style="font: inherit;"> June 30, 2023</em> (18%, 14% and 10%).</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">During the <em style="font: inherit;">six</em> months ended <em style="font: inherit;"> June 30, 2024</em>, the Company had <span style="-sec-ix-hidden:c114144083">two</span> customers with sales of <em style="font: inherit;">10%</em> or more of the Company’s total reve<span style="background-color:#ffffff;">nue (12% and 10%), a</span>s compared with <span style="-sec-ix-hidden:c114144087">two</span> customers in the <em style="font: inherit;">six</em> months ended <em style="font: inherit;"> June 30, 2023</em> (16% and 13%).</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"></p>
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
345000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
345000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
383000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-204000 usd
CY2024Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
3983000 usd
CY2023Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
4298000 usd
CY2024Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
217000 usd
CY2023Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
290000 usd
CY2024Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
774000 usd
CY2023Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
462000 usd
CY2024Q2 us-gaap Inventory Net
InventoryNet
4974000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
5050000 usd
CY2024Q2 ekso Contract With Customer Liability Extended Maintenance And Support
ContractWithCustomerLiabilityExtendedMaintenanceAndSupport
3786000 usd
CY2023Q4 ekso Contract With Customer Liability Extended Maintenance And Support
ContractWithCustomerLiabilityExtendedMaintenanceAndSupport
3993000 usd
CY2024Q2 ekso Contract With Customer Liability Devices And Advances
ContractWithCustomerLiabilityDevicesAndAdvances
156000 usd
CY2023Q4 ekso Contract With Customer Liability Devices And Advances
ContractWithCustomerLiabilityDevicesAndAdvances
169000 usd
CY2024Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
3942000 usd
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
4162000 usd
CY2024Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1926000 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1993000 usd
CY2024Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
2016000 usd
CY2023Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
2169000 usd
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
4162000 usd
ekso Contract With Customer Liability Deferral Of Revenue
ContractWithCustomerLiabilityDeferralOfRevenue
1166000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
-1386000 usd
CY2024Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
3942000 usd
CY2024Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
1162000 usd
CY2024Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
1351000 usd
CY2024Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
1429000 usd
CY2024Q2 ekso Contract With Customer Liability Noncancellable Backlog
ContractWithCustomerLiabilityNoncancellableBacklog
2872000 usd
CY2024Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
4950000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
4703000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
8706000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
8825000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
345000 usd
CY2024Q2 ekso Finitelived Intangible Asset Expected Amortization After Year Four
FinitelivedIntangibleAssetExpectedAmortizationAfterYearFour
896000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2429000 usd
CY2024Q2 ekso Acquired Finitelived Intangible Asset Amortization
AcquiredFinitelivedIntangibleAssetAmortization
77000 usd
CY2023Q2 ekso Acquired Finitelived Intangible Asset Amortization
AcquiredFinitelivedIntangibleAssetAmortization
82000 usd
CY2024Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1459000 usd
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2058000 usd
CY2024Q2 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
417000 usd
CY2023Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
461000 usd
CY2024Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
97000 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
145000 usd
CY2024Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1973000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2664000 usd
CY2024Q2 us-gaap Goodwill
Goodwill
431000 usd
CY2024Q2 us-gaap Below Market Lease Gross
BelowMarketLeaseGross
5220000 usd
CY2024Q2 us-gaap Below Market Lease Accumulated Amortization
BelowMarketLeaseAccumulatedAmortization
481000 usd
CY2024Q2 us-gaap Below Market Lease Net
BelowMarketLeaseNet
4739000 usd
CY2023Q4 us-gaap Below Market Lease Gross
BelowMarketLeaseGross
5220000 usd
CY2023Q4 us-gaap Below Market Lease Accumulated Amortization
BelowMarketLeaseAccumulatedAmortization
328000 usd
CY2023Q4 us-gaap Below Market Lease Net
BelowMarketLeaseNet
4892000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
153000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
345000 usd
ekso Acquired Finitelived Intangible Asset Amortization
AcquiredFinitelivedIntangibleAssetAmortization
153000 usd
ekso Acquired Finitelived Intangible Asset Amortization
AcquiredFinitelivedIntangibleAssetAmortization
163000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
248000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
483000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
432000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
41000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1204000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
115000 usd
CY2024Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
1089000 usd
CY2024Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y4M17D
CY2024Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.083 pure
CY2024Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
135000 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
271000 usd
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
141429000
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
18444000
CY2024Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
5000000 usd
CY2023Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1240000
ekso Class Of Warrant Or Right Issued
ClassOfWarrantOrRightIssued
0
CY2024Q2 ekso Class Of Warrant Or Right Expired
ClassOfWarrantOrRightExpired
-193000
ekso Class Of Warrant Or Right Exercised
ClassOfWarrantOrRightExercised
0
CY2024Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1047000
CY2024Q2 ekso Class Of Warrant Or Warrants Exercised
ClassOfWarrantOrWarrantsExercised
0
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2024Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
0 usd
CY2024Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
285000 usd
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
514000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
660000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
938000 usd
us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
0.50 pure
ekso Common Stock Contribution
CommonStockContribution
113000 usd
ekso Common Stock Contribution
CommonStockContribution
219000 usd
CY2024Q2 us-gaap Purchase Obligation
PurchaseObligation
2137000 usd
CY2023Q4 us-gaap Purchase Obligation
PurchaseObligation
2783000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1204000 usd
CY2024Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2416000 usd
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-4230000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-5845000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-8619000 usd
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
18224000
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13637000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17822000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13467000
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.13
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.31
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.33
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.64
CY2024Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2321000
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3056000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2321000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3056000
CY2024Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
4950000 usd
CY2024Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2313000 usd
CY2024Q2 us-gaap Gross Profit
GrossProfit
2637000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
4703000 usd
CY2023Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2449000 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
2254000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
8706000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
4118000 usd
us-gaap Gross Profit
GrossProfit
4588000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
8825000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
4571000 usd
us-gaap Gross Profit
GrossProfit
4254000 usd
CY2024Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
4950000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
4703000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
8706000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
8825000 usd

Files In Submission

Name View Source Status
0001437749-24-023765-index-headers.html Edgar Link pending
0001437749-24-023765-index.html Edgar Link pending
ekso-20240630_cal.xml Edgar Link unprocessable
0001437749-24-023765.txt Edgar Link pending
0001437749-24-023765-xbrl.zip Edgar Link pending
ekso-20240630.xsd Edgar Link pending
ekso20240630_10q.htm Edgar Link pending
ex_676558.htm Edgar Link pending
ex_676559.htm Edgar Link pending
ex_676560.htm Edgar Link pending
ex_676561.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
ekso-20240630_def.xml Edgar Link unprocessable
ekso-20240630_lab.xml Edgar Link unprocessable
ekso-20240630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
ekso20240630_10q_htm.xml Edgar Link completed
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending